Agilent SPONSORED CONTENT

Quality Assurance in In Vitro Transcribed (IVT) Vaccine Development using Agilent Automated Electrophoresis Instruments

November 01, 2022
Quality Assurance in In Vitro RNA Vaccine

As infectious diseases spread worldwide, there is an urgent need for rapid development and distribution of vaccines. In vitro transcribed (IVT) RNA vaccines have emerged as a valuable tool against infectious diseases by being highly adaptable, efficient and ideally suited for fast production. Download this white paper to learn how these vaccines address the rising need for robust, reliable and high-throughput testing.

Download Now

    Please fill out the information below to request information on the content you selected. If you are already registered, or have requested a quote before, and this information will be filled out for you.
  • By submitting this form, you consent to Biocompare storing your email address and contact information and transmitting your contact information to the Future Lab sponsor. You also agree to receive email from Biocompare and the sponsor. You may request to be removed at any time.